The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs from the IRA’s drug price negotiation program—a move welcomed by the ...

The Inflation Reduction Act imposed a 15-percent "alternative minimum tax" on large corporations in 2022. The idea was to keep big companies from using complex accounting tricks and IRS loopholes to ...

The House passed the “One Big Beautiful Bill Act” on July 3, which includes sweeping changes to healthcare and some pharma-related provisions.

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

Risks to BMY include potential for tariffs to raise costs of drugs manufactured outside of the U.S. Moreover, drug pricing ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...